According to InfuSystem's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.75436. At the end of 2023 the company had a P/S ratio of 1.71.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.71 | 4.53% |
2022 | 1.63 | -52.62% |
2021 | 3.44 | -12.03% |
2020 | 3.91 | 87.21% |
2019 | 2.09 | 108.44% |
2018 | 1.00 | 36.07% |
2017 | 0.7372 | -7.94% |
2016 | 0.8008 | -15.16% |
2015 | 0.9439 | -10.7% |
2014 | 1.06 | 40.07% |
2013 | 0.7546 | 35.73% |
2012 | 0.5559 | -11.2% |
2011 | 0.6260 | -43.77% |
2010 | 1.11 | 5.25% |
2009 | 1.06 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Premier PINC | 1.96 | 11.80% | ๐บ๐ธ USA |
![]() DexCom DXCM | 2.80 | 59.56% | ๐บ๐ธ USA |
![]() CorVel Corporation
CRVL | 4.58 | 160.91% | ๐บ๐ธ USA |
![]() Biolase
BIOL | 0.0948 | -94.60% | ๐บ๐ธ USA |